Use of inhaled corticosteroids and the risk of osteoporosis: an international cohort study

A. Grosso (Pavia, Italy), L. Cazzoletti (Verona, Italy), F. Albicini (Pavia, Italy), E. Gini (Pavia, Italy), E. Zanolin (Verona, Italy), V. Ronzoni (Pavia, Italy), V. Conio (Pavia, Italy), R. Di Domenica (Pavia, Italy), A. Corsico (Pavia, Italy), D. Jarvis (London, United Kingdom), C. Janson (Uppsala, Sweden), I. Cerveri (Pavia, Italy)

Source: International Congress 2018 – Epidemiology of asthma, COPD and factors that associate with lung function
Session: Epidemiology of asthma, COPD and factors that associate with lung function
Session type: Thematic Poster
Number: 4481
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Grosso (Pavia, Italy), L. Cazzoletti (Verona, Italy), F. Albicini (Pavia, Italy), E. Gini (Pavia, Italy), E. Zanolin (Verona, Italy), V. Ronzoni (Pavia, Italy), V. Conio (Pavia, Italy), R. Di Domenica (Pavia, Italy), A. Corsico (Pavia, Italy), D. Jarvis (London, United Kingdom), C. Janson (Uppsala, Sweden), I. Cerveri (Pavia, Italy). Use of inhaled corticosteroids and the risk of osteoporosis: an international cohort study. 4481

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Osteoporosis and fracture risk associated with inhaled corticosteroid use among Swedish COPD patients: the ARCTIC study
Source: Eur Respir J, 57 (2) 2000515; 10.1183/13993003.00515-2020
Year: 2021



Changing prevalence of current asthma and inhaled corticosteroid treatment in the UK: population-based cohort 2006–2016
Source: Eur Respir J, 53 (4) 1802130; 10.1183/13993003.02130-2018
Year: 2019



Long-term inhaled corticosteroid use in COPD and the risk of fracture in men and women
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016


Concurrent use of long-acting bronchodilators in COPD and the risk of adverse cardiovascular events: A population-based study
Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations
Year: 2016


Inhaled corticosteroids and the risk of lung cancer in COPD: a population-based cohort study
Source: Eur Respir J, 53 (6) 1801257; 10.1183/13993003.01257-2018
Year: 2019



Inhaled corticosteroid therapy and risk of hospitalization with pneumonia: a population-based case-control study from Denmark
Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia
Year: 2009


Changes in the use of anti-asthmatic medication in an international cohort
Source: Eur Respir J 2005; 26: 1047-1055
Year: 2005



The use of high-dose inhaled corticosteroids and add-on therapy in children in the UK: an observational study of 4332 patients
Source: Annual Congress 2004 - New aspects of drug therapy in paediatric asthma
Year: 2004


Asthma control with inhaled corticosteroid therapy: A real-world observational study
Source: Annual Congress 2010 - Management of airway disease
Year: 2010

Evaluating inhaled corticosteroid use among pregnant women with asthma: systematic review and meta-analysis
Source: International Congress 2019 – Asthma treatment: cohorts and real-world studies
Year: 2019


High-dose inhaled corticosteroids and add-on therapy use in adults in the UK: an observational study of 22,027 patients
Source: Annual Congress 2004 - Primary care: asthma
Year: 2004


Use of antidepressive agents in COPD patients: experience in a large Canadian cohort
Source: Annual Congress 2008 - Comorbidities in COPD
Year: 2008


Inhaled steroids doses to obtain asthma control in children: a randomised concurrent cohort study
Source: Annual Congress 2009 - Clinical advances in childhood asthma
Year: 2009


COVID-19 risk and outcomes in adult asthmatics treated with biologics or systemic corticosteroids: nationwide real-world evidence.
Source: Virtual Congress 2021 – Asthma treatment: clinical and translational science
Year: 2021



A new user cohort study comparing the risk of pneumonia in inhaled corticosteroid (ICS) vs. long-acting bronchodilator (LABD) regimens in COPD
Source: Annual Congress 2013 –Risk factors for COPD and lung function decline
Year: 2013

Long-acting bronchodilator initiation in COPD and cardio-pulmonary risks: A population-based comparative effectiveness study
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016


Three-year prospective cohort study of growth in asthmatic children prescribed appropriate inhaled corticosteroid (ICS) doses
Source: Eur Respir J 2004; 24: Suppl. 48, 614s
Year: 2004

Late Breaking Abstract - Use of inhaled corticosteroids and the risk of lung cancer, the HUNT study
Source: International Congress 2017 – Lung cancer - basic science: the latest results from the bench
Year: 2017

Step-up of asthma therapy: an observational study comparing increased inhaled corticosteroid dosage to combination inhaled corticosteroid/long acting beta agonist therapy in UK general practice
Source: Annual Congress 2007 - Traditional and novel approaches to assess and achieve asthma control
Year: 2007


Inhaled corticosteroid withdrawal may improve outcomes in elderly patients with COPD exacerbation: a nationwide database study
Source: ERJ Open Res, 6 (1) 00246-2019; 10.1183/23120541.00246-2019
Year: 2020